Both in Pharmaceuticals
ALX Oncology Holdings vs Cartesian Therapeutics
Over the past year ALXO returned −12.7% and RNAC returned −22.0%; their daily moves had a correlation of 0.17.
ALXO −12.7% RNAC −22.0%Growth of $1, one year, split-adjusted
| Metric | ALXO | RNAC |
|---|---|---|
| Price | $1.37 | $6.34 |
| Market cap | $189.4M | $191.8M |
| Today | +12.30% | −2.31% |
| 1 month | +12.3% | −13.9% |
| 6 months | −27.1% | −8.5% |
| Year to date | +21.2% | −12.1% |
| 1 year | −11.6% | −21.8% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 129.9× |
| Net cash | $128.5M | $94.8M |
| Dividend yield | — | — |
| Volatility (60d) | 92.5% | 48.9% |
| Short % of float | 6.5% | 15.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).